Literature DB >> 33751431

Continuous and Discontinuous Approaches to Study FAD Synthesis and Degradation Catalyzed by Purified Recombinant FAD Synthase or Cellular Fractions.

Piero Leone1, Maria Tolomeo1, Maria Barile2.   

Abstract

Riboflavin, or vitamin B2, is the precursor of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), essential redox (and sometimes non-redox) cofactors of a large number of flavoenzymes involved in energetic metabolism, protein folding, apoptosis, chromatin remodeling, and a number of other cell regulatory processes.The cellular and subcellular steady-state concentrations of flavin cofactors, which are available for flavoprotein biogenesis and assembly, depend on carrier-mediated transport processes and on coordinated synthesizing/destroying enzymatic activities, catalyzed by enzymes whose catalytic and structural properties are still matter of investigation.Alteration of flavin homeostasis has been recently correlated to human pathological conditions, such as neuromuscular disorders and cancer, and therefore we propose here protocols useful to detect metabolic processes involved in FAD forming and destroying.Our protocols exploit the chemical-structural differences between riboflavin, FMN , and FAD , which are responsible for differences in the spectroscopic properties (mainly fluorescence) of the two cofactors (FMN and FAD); therefore, in our opinion, when applicable measurements of fluorescence changes in continuo represent the elective techniques to follow FAD synthesis and degradation. Thus, after procedures able to calibrate flavin concentrations (Subheading 3.1), we describe simple continuous and rapid procedures, based on the peculiar optical properties of free flavins, useful to determine the rate of cofactor metabolism catalyzed by either recombinant enzymes or natural enzymes present in cellular lysates/subfractions (Subheading 3.2).Fluorescence properties of free flavins can also be useful in analytical determinations of the three molecular flavin forms, based on HPLC separation, with a quite high sensitivity. Assaying at different incubation times the molecular composition of the reaction mixture is a discontinuous experimental approach to measure the rate of FAD synthesis/degradation catalyzed by cell lysates or recombinant FAD synthase (Subheading 3.3). Continuous and discontinuous approaches can, when necessary, be performed in parallel.

Entities:  

Keywords:  Degradation; Fluorescence changes; HPLC separation; Synthesis

Mesh:

Substances:

Year:  2021        PMID: 33751431     DOI: 10.1007/978-1-0716-1286-6_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  47 in total

Review 1.  Riboflavin transport and metabolism in humans.

Authors:  Maria Barile; Teresa Anna Giancaspero; Piero Leone; Michele Galluccio; Cesare Indiveri
Journal:  J Inherit Metab Dis       Date:  2016-06-06       Impact factor: 4.982

Review 2.  Two interconnected B vitamins: riboflavin and pyridoxine.

Authors:  D B McCormick
Journal:  Physiol Rev       Date:  1989-10       Impact factor: 37.312

Review 3.  Introduction: flavoprotein structure and mechanism.

Authors:  V Massey
Journal:  FASEB J       Date:  1995-04       Impact factor: 5.191

Review 4.  Formation and mode of action of flavoproteins.

Authors:  A H Merrill; J D Lambeth; D E Edmondson; D B McCormick
Journal:  Annu Rev Nutr       Date:  1981       Impact factor: 11.848

Review 5.  Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism.

Authors:  Flore Depeint; W Robert Bruce; Nandita Shangari; Rhea Mehta; Peter J O'Brien
Journal:  Chem Biol Interact       Date:  2006-05-01       Impact factor: 5.192

Review 6.  Disorders of riboflavin metabolism.

Authors:  Shanti Balasubramaniam; John Christodoulou; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2019-03-11       Impact factor: 4.982

Review 7.  Riboflavin (vitamin B-2) and health.

Authors:  Hilary J Powers
Journal:  Am J Clin Nutr       Date:  2003-06       Impact factor: 7.045

8.  The Expression of Riboflavin Transporters in Human Colorectal Cancer.

Authors:  Valeria Tutino; Marianna Loredana Defrancesco; Maria Tolomeo; Valentina DE Nunzio; Dionigi Lorusso; Didier Paleni; Maria Gabriella Caruso; Maria Notarnicola; Maria Barile
Journal:  Anticancer Res       Date:  2018-05       Impact factor: 2.480

9.  Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency.

Authors:  Rikke K J Olsen; Eliška Koňaříková; Teresa A Giancaspero; Signe Mosegaard; Veronika Boczonadi; Lavinija Mataković; Alice Veauville-Merllié; Caterina Terrile; Thomas Schwarzmayr; Tobias B Haack; Mari Auranen; Piero Leone; Michele Galluccio; Apolline Imbard; Purificacion Gutierrez-Rios; Johan Palmfeldt; Elisabeth Graf; Christine Vianey-Saban; Marcus Oppenheim; Manuel Schiff; Samia Pichard; Odile Rigal; Angela Pyle; Patrick F Chinnery; Vassiliki Konstantopoulou; Dorothea Möslinger; René G Feichtinger; Beril Talim; Haluk Topaloglu; Turgay Coskun; Safak Gucer; Annalisa Botta; Elena Pegoraro; Adriana Malena; Lodovica Vergani; Daniela Mazzà; Marcella Zollino; Daniele Ghezzi; Cecile Acquaviva; Tiina Tyni; Avihu Boneh; Thomas Meitinger; Tim M Strom; Niels Gregersen; Johannes A Mayr; Rita Horvath; Maria Barile; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

Review 10.  Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.

Authors:  Bregje Jaeger; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2016-03-14       Impact factor: 4.982

View more
  1 in total

1.  Combined isobutyryl-CoA and multiple acyl-CoA dehydrogenase deficiency in a boy with altered riboflavin homeostasis.

Authors:  Albina Tummolo; Piero Leone; Maria Tolomeo; Rita Solito; Matteo Mattiuzzo; Francesca Romana Lepri; Tania Lorè; Roberta Cardinali; Donatella De Giovanni; Simonetta Simonetti; Maria Barile
Journal:  JIMD Rep       Date:  2022-05-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.